Page last updated: 2024-09-04

abiraterone and Cell Transformation, Neoplastic

abiraterone has been researched along with Cell Transformation, Neoplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armstrong, CM; Evans, CP; Gao, AC; Liu, C; Lombard, A; Lou, W	1

Other Studies

1 other study(ies) available for abiraterone and Cell Transformation, Neoplastic

Article	Year
Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer. Molecular cancer therapeutics, 2017, Volume: 16, Issue:1 Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Androstenes; Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Mice; Neoplasm Staging; Prostatic Neoplasms; Receptors, Androgen; Transcription, Genetic; Xenograft Model Antitumor Assays	2017

Article

Year

Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer.

Molecular cancer therapeutics, 2017, Volume: 16, Issue:1

Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Androstenes; Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Mice; Neoplasm Staging; Prostatic Neoplasms; Receptors, Androgen; Transcription, Genetic; Xenograft Model Antitumor Assays

2017